Literature DB >> 28711090

The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.

Lavanya Mittal1, Victoria P Werth2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28711090      PMCID： PMC5843483          DOI： 10.1016/j.jaad.2017.03.027

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Aplastic anemia induced by quinacrine.

Authors:  L Biro; N Leone
Journal:  Arch Dermatol       Date:  1965-11

2.  Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis.

Authors:  Aileen Y Chang; Evan W Piette; Kristen P Foering; Thomas R Tenhave; Joyce Okawa; Victoria P Werth
Journal:  Arch Dermatol       Date:  2011-07-18

3.  Impact of smoking in cutaneous lupus erythematosus.

Authors:  Evan W Piette; Kristen P Foering; Aileen Y Chang; Joyce Okawa; Thomas R Ten Have; Rui Feng; Victoria P Werth
Journal:  Arch Dermatol       Date:  2011-11-21

4.  Aplastic anemia in soldiers treated with atabrine (quinacrine).

Authors:  R P CUSTER
Journal:  Am J Med Sci       Date:  1946-08       Impact factor: 2.378
  4 in total
  5 in total

Review 1.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.

Authors:  Lavanya Mittal; Lingqiao Zhang; Rui Feng; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-10-06       Impact factor: 11.527

Review 3.  Aminoquinoline antimalarial therapy in dermatomyositis-are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity?

Authors:  Richard D Sontheimer
Journal:  Ann Transl Med       Date:  2018-04

Review 4.  Current Treatment for Myositis.

Authors:  Simone Barsotti; Ingrid E Lundberg
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-09-15

5.  Response of dermatomyositis to the antimalarial quinacrine: A retrospective cohort study.

Authors:  Adarsh Ravishankar; Daisy Yan; Christina E Bax; Josef S Concha; Rui Feng; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2020-07-23       Impact factor: 11.527
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.